The large effect of aspirin on colorectal cancers has been suggested to be unlikely due to effects on PIK3CA tumours alone as these only account for 10–20 % of such cancers [263], but as discussed earlier, there are many other potential aberrations in this pathway in cancers with which COX-2 inhibitors may interact. The gene discussed is PIK3CA; the disease is neoplasm.